What is Nouveau Life Pharmaceuticals’s market cap?
Nouveau Life Pharmaceuticals’s market cap is $6,661.
When is Nouveau Life Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Nouveau Life Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nouveau Life Pharmaceuticals pay dividends?
Nouveau Life Pharmaceuticals does not currently pay dividends.
What is Nouveau Life Pharmaceuticals’s EPS estimate?
Nouveau Life Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nouveau Life Pharmaceuticals have?
Nouveau Life Pharmaceuticals has 6,660,964,000 shares outstanding.
Which hedge fund is a major shareholder of Nouveau Life Pharmaceuticals?
Currently, no hedge funds are holding shares in NOUV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nouveau Life Pharmaceuticals
Nouveau Life Pharmaceuticals, Inc. (NOUV) is a company in its developmental stage, primarily focused on crafting nutraceutical products. It offers both natural health solutions and pharmaceutical drugs. The entity, which began operations in 1998, was previously known as Hybrid Fuels, Inc. before adopting its current designation in May 2012. Based in Ft. Lauderdale, Florida, Nouveau Life Pharmaceuticals, Inc. functions as an affiliate of EMG Marketing Solutions, Inc.